Kevin S.
Founding Partner @ Beacon Capital Partner
About
Cross-border (US-China) specialist with extensive sourcing and deal origination capability across sectors (consumer, TMT, healthcare) and alternative assets (PEVC, private credit, secondaries). Significant local network in China within both USD and RMB PEVC ecosystem. Co-founded Beacon Capital Partner in 2024 amid growing geopolitical tensions and domestic economic slowdown, hoping to create values for biotech companies and their shareholders while generating meaningful returns for global life sciences investors through New Co. and subsidiary model (Hub-and-Spoke). Pipelines and live deals cover 6 major therapeutic areas - Oncology, Immunology & Inflammation, Cardiovascular, Metabolism & Endocrine, Kidney, CNS - and 4 modalities - biologics, small molecule, ADC, and siRNA kevin.sheng@beacon-cp.com
China
Shanghai
Financial Services
Private Equity, Private Credit, Secondaries, GP Stakes, Cross-border Transactions
Experience
Founding Partner
Beacon Capital Partner
Hong Kong SAR
Beacon Capital Partner (BCP) is a boutique strategic advisory firm focusing on New Co. creation under global life sciences investors and their portfolios through in-licensing clinical and pre-clinical stage BIC and FIC therapeutics from Chinese scientist-founded biotechnology companies. Named after "Beacon Street", a major east-west street in Boston, BCP seeks to connect the east and west globally in life sciences, creating better standard of care for both the citizens of United States and China.
Investment Banking Divison
Jefferies
Hong Kong SAR
Employee #1 focusing on liquidity and monetization solutions for sponsors and corporations in Asia
Financial Sponsor Advisory
Co-Win Venture Resources
Hong Kong SAR
- Led by one of the earliest members of IDG Capital, the team has 20+ years of cross-border experience in private placement, fund raising, and secondaries transactions. Selected Track Record: - Advised Hepalink (pharmaceutical) fundraising from Goldman Sachs PIA, 235x MoIC - Advised Softbank Asia Infrastructure Fund (SAIF) on the growth investment of Eternal Asia (supply chain) - Advised Morgan Stanley PE Asia on the growth investment of KNX (SaaS) - Advised a shared workspaces company Series B fundraising from Sequoia China - Advised CDH on the buyout of a stainless steel company
Capital Formation
CBC Group
Shanghai, China
#1 Private Equity International 300 Asia Healthcare Capital raising for flagship buyout fund ($1.7B), healthcare royalties, healthcare real estate, healthcare long/short
Private Equity Direct Investment, Business Services
CDH Investments
Shanghai, China
#7 China Venture Top 100 Private Equity Firm Direct investment sourcing & execution
Private Equity Direct Investment, Advanced Manufacturing
CoStone Capital 基石资本
Shenzhen, Guangdong, China
#9 China Venture Top 100 Private Equity Firm Direct investment execution and portfolio management/value-add
Education
Boston College Carroll School of Management
Double Major in Finance and Accounting
Davidson College
Medicinal and Pharmaceutical Chemistry
Boston College
Minor in Philosophy
Cornell University
Behavioral Psychology
Kevin S.'s Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.